{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:50:20Z","timestamp":1775976620628,"version":"3.50.1"},"posted":{"date-parts":[[2025,3,16]]},"group-title":"Neuroscience","reference-count":51,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:00:00Z","timestamp":1742083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,3,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Huntington\u2019s disease (HD) is a progressive neurodegenerative disorder caused by a CAG-repeat expansion in exon-1 of the\n                  <jats:italic>huntingtin<\/jats:italic>\n                  gene. Currently, no disease-modifying therapies are available, with a significant challenge in evaluating therapeutic efficacy before clinical symptoms emerge. This highlights the need for early biomarkers and intervention strategies. Therefore, it is essential to develop and characterize accurate mouse models and identify early biomarkers for preclinical therapeutic development. In this study, we characterized the pathological progression of the heterozygous zQ175 neo-deleted knock in (zQ175DN) mouse model across four age groups: 3, 6, 10, and 16 months to identify human translatable outcome measures. T2-relaxation-under-spin-tagging (TRUST) MRI was used to assess global CMRO\n                  <jats:sub>2<\/jats:sub>\n                  , while T2-weighted MRI was used to analyze brain volumes. Significant brain volume loss was detected as early as 6 months of age, worsening progressively with age in the zQ175 DN mice, resembling HD brain volumetric changes. A decline in CMRO\n                  <jats:sub>2<\/jats:sub>\n                  was observed in 6-month-old zQ175 DN mice, with significant and progressive reductions in 10- and 16-months old HD mice. Additionally, PHP1-positive mutant huntingtin (mHTT) aggregates were present in the striatum of zQ175 DN mice at all four age groups, with intranuclear localization prior to 6 months, transitioning to both intranuclear and neuropil aggregates in older zQ175 DN mice, suggesting that the localization of mHTT aggregates may reflect the severity of HD pathogenesis. Interestingly, plasma neurofilament light chain (NfL) protein concentrations were significantly elevated at 6 months of age and older zQ175DN mice. These findings provide valuable insights for selecting outcome measures in preclinical evaluations of HD therapies using the zQ175 DN mouse model.\n                <\/jats:p>","DOI":"10.1101\/2025.03.16.643551","type":"posted-content","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T16:08:44Z","timestamp":1742400524000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington\u2019s disease"],"prefix":"10.64898","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Yao","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongshuai","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Kakazu","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiao","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoxuan","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmane","family":"Surasinghe","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Gerochi","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Baldo","sequence":"additional","affiliation":[{"name":"Evotec SE, Manfred Eigen Campus, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Jahn","sequence":"additional","affiliation":[{"name":"Evotec SE, Manfred Eigen Campus, Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Tang","sequence":"additional","affiliation":[{"name":"CHDI Management for CHDI Foundation, Princeton, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhang","family":"Lu","sequence":"additional","affiliation":[{"name":"The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiliang","family":"Wei","sequence":"additional","affiliation":[{"name":"The Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhen","family":"Duan","sequence":"additional","affiliation":[{"name":"Division of Neurobiology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of medicine, Baltimore, Maryland, USA"},{"name":"Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"},{"name":"Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026041123183002000_2025.03.16.643551v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.12.2353"},{"issue":"2","key":"2026041123183002000_2025.03.16.643551v1.2","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease","volume":"47","year":"2006","journal-title":"J Nucl Med"},{"key":"2026041123183002000_2025.03.16.643551v1.3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm217"},{"key":"2026041123183002000_2025.03.16.643551v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3445-y"},{"key":"2026041123183002000_2025.03.16.643551v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2008.12.015"},{"key":"2026041123183002000_2025.03.16.643551v1.6","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200305"},{"key":"2026041123183002000_2025.03.16.643551v1.7","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70055"},{"key":"2026041123183002000_2025.03.16.643551v1.8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26006"},{"key":"2026041123183002000_2025.03.16.643551v1.9","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw212"},{"key":"2026041123183002000_2025.03.16.643551v1.10","doi-asserted-by":"crossref","unstructured":"Wu J , Mohle L , Bruning T , et al. A Novel Huntington\u2019s Disease Assessment Platform to Support Future Drug Discovery and Development. Int J Mol Sci. 2022;23(23).","DOI":"10.3390\/ijms232314763"},{"key":"2026041123183002000_2025.03.16.643551v1.11","doi-asserted-by":"crossref","unstructured":"Speziale R , Montesano C , Di Pietro G , et al. The Urine Metabolome of R6\/2 and zQ175DN Huntington\u2019s Disease Mouse Models. Metabolites. 2023;13(8).","DOI":"10.3390\/metabo13080961"},{"key":"2026041123183002000_2025.03.16.643551v1.12","doi-asserted-by":"crossref","unstructured":"Bates GP , Dorsey R , Gusella JF , et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005.","DOI":"10.1038\/nrdp.2015.5"},{"key":"2026041123183002000_2025.03.16.643551v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.24"},{"key":"2026041123183002000_2025.03.16.643551v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801893-4.00020-1"},{"key":"2026041123183002000_2025.03.16.643551v1.15","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1427.018"},{"key":"2026041123183002000_2025.03.16.643551v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2009.09.013"},{"key":"2026041123183002000_2025.03.16.643551v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2009.07.010"},{"issue":"1","key":"2026041123183002000_2025.03.16.643551v1.18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbadis.2009.06.008","article-title":"Impaired mitochondrial trafficking in Huntington\u2019s disease","volume":"1802","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2026041123183002000_2025.03.16.643551v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2011.10.016"},{"key":"2026041123183002000_2025.03.16.643551v1.20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45691"},{"key":"2026041123183002000_2025.03.16.643551v1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.06.021"},{"key":"2026041123183002000_2025.03.16.643551v1.22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69411"},{"key":"2026041123183002000_2025.03.16.643551v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25009"},{"key":"2026041123183002000_2025.03.16.643551v1.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6099-5"},{"key":"2026041123183002000_2025.03.16.643551v1.25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25010"},{"key":"2026041123183002000_2025.03.16.643551v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.157"},{"key":"2026041123183002000_2025.03.16.643551v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.104"},{"key":"2026041123183002000_2025.03.16.643551v1.28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.12.2689"},{"key":"2026041123183002000_2025.03.16.643551v1.29","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X20949286"},{"key":"2026041123183002000_2025.03.16.643551v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy141"},{"key":"2026041123183002000_2025.03.16.643551v1.31","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4568"},{"key":"2026041123183002000_2025.03.16.643551v1.32","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.27046"},{"key":"2026041123183002000_2025.03.16.643551v1.33","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.27592"},{"key":"2026041123183002000_2025.03.16.643551v1.34","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4207"},{"key":"2026041123183002000_2025.03.16.643551v1.35","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.27823"},{"key":"2026041123183002000_2025.03.16.643551v1.36","doi-asserted-by":"publisher","DOI":"10.1007\/s10334-011-0287-2"},{"key":"2026041123183002000_2025.03.16.643551v1.37","doi-asserted-by":"publisher","DOI":"10.1007\/BF00695604"},{"key":"2026041123183002000_2025.03.16.643551v1.38","doi-asserted-by":"publisher","DOI":"10.1364\/BOE.6.003941"},{"key":"2026041123183002000_2025.03.16.643551v1.39","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199907000-00012"},{"key":"2026041123183002000_2025.03.16.643551v1.40","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab190"},{"key":"2026041123183002000_2025.03.16.643551v1.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148839"},{"key":"2026041123183002000_2025.03.16.643551v1.42","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.21994"},{"key":"2026041123183002000_2025.03.16.643551v1.43","doi-asserted-by":"crossref","unstructured":"Jarosinska OD , Rudiger SGD . Molecular Strategies to Target Protein Aggregation in Huntington\u2019s Disease. Front Mol Biosci. 2021;8:769184.","DOI":"10.3389\/fmolb.2021.769184"},{"key":"2026041123183002000_2025.03.16.643551v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2018.03.017"},{"key":"2026041123183002000_2025.03.16.643551v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2019.108334"},{"key":"2026041123183002000_2025.03.16.643551v1.46","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.5b00281"},{"key":"2026041123183002000_2025.03.16.643551v1.47","doi-asserted-by":"crossref","unstructured":"Lin HK , Boatz JC , Krabbendam IE , et al. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core. Nat Commun. 2017;8:15462.","DOI":"10.1038\/ncomms15462"},{"key":"2026041123183002000_2025.03.16.643551v1.48","doi-asserted-by":"crossref","unstructured":"Shen K , Calamini B , Fauerbach JA , et al. Control of the structural landscape and neuronal proteotoxicity of mutant Huntingtin by domains flanking the polyQ tract. Elife. 2016;5.","DOI":"10.7554\/eLife.18065"},{"key":"2026041123183002000_2025.03.16.643551v1.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12700-x"},{"key":"2026041123183002000_2025.03.16.643551v1.50","doi-asserted-by":"crossref","unstructured":"Rodrigues FB , Byrne LM , Tortelli R , et al. Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington\u2019s disease. Sci Transl Med. 2020;12(574).","DOI":"10.1126\/scitranslmed.abc2888"},{"key":"2026041123183002000_2025.03.16.643551v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30124-2"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.03.16.643551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:18:40Z","timestamp":1775974720000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.03.16.643551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,16]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1101\/2025.03.16.643551","relation":{},"subject":[],"published":{"date-parts":[[2025,3,16]]},"subtype":"preprint"}}